Mary Afihene
Overview
Explore the profile of Mary Afihene including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
406
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tazinkeng N, Monteiro J, Thomson S, David Y, Madkour A, Katsidzira L, et al.
Lancet Gastroenterol Hepatol
. 2023 Dec;
9(3):195-197.
PMID: 38061377
No abstract available.
2.
Abou-Alfa G, Afihene M, Capanu M, Li Y, Chou J, Asombang A, et al.
JCO Glob Oncol
. 2023 Nov;
9:e2300159.
PMID: 37944087
Purpose: Hepatocellular carcinoma (HCC), the fourth most common cancer in Africa, has a dismal overall survival of only 3 months like in sub-Saharan Africa. This is affected by the low...
3.
Wiafe Y, Anyitey-Kokor I, Nmai R, Afihene M, Roberts L
Cureus
. 2023 Jun;
15(6):e40756.
PMID: 37350981
Introduction Brightness mode ultrasound (B-mode US) and FibroScan (Echosens, Paris, France) are the two ultrasound methods often recommended for screening non-alcoholic fatty liver disease (NAFLD) in persons with type 2...
4.
Karstensen J, Ebigbo A, Desalegn H, Afihene M, Anigbo G, Antonelli G, et al.
Endosc Int Open
. 2022 Nov;
10(11):E1427-E1433.
PMID: 36397871
No abstract available.
5.
Spearman C, Dusheiko G, Jonas E, Abdo A, Afihene M, Cunha L, et al.
Lancet Gastroenterol Hepatol
. 2022 Jul;
7(11):1036-1048.
PMID: 35810766
Hepatocellular carcinoma is a leading public health concern in sub-Saharan Africa, and it is most prevalent in young adults (median 45 years [IQR 35-57]). Overall, outcomes are poor, with a...
6.
Spearman C, Afihene M, Betiku O, Bobat B, Cunha L, Kassianides C, et al.
Lancet Gastroenterol Hepatol
. 2021 Sep;
6(12):1036-1046.
PMID: 34508671
Non-alcoholic fatty liver disease (NAFLD) is the leading cause of chronic liver disease globally and is estimated to affect approximately 25% of the world's population. Data about the prevalence and...
7.
Gupta N, Desalegn H, Ocama P, Lacombe K, Njouom R, Afihene M, et al.
Lancet Gastroenterol Hepatol
. 2020 Jun;
5(7):634-636.
PMID: 32553140
No abstract available.
8.
Karstensen J, Ebigbo A, Aabakken L, Dinis-Ribeiro M, Gralnek I, Le Moine O, et al.
Endosc Int Open
. 2018 Oct;
6(10):E1256-E1263.
PMID: 30302383
No abstract available.
9.
Owusu M, Bonney J, Annan A, Mawuli G, Okyere K, Mutocheluh M, et al.
PLoS One
. 2018 Sep;
13(9):e0203699.
PMID: 30208084
Background: Viral hepatitis continues to play significant role in causing morbidity and mortality in sub-Saharan Africa. Apart from the few population based studies available, not many have investigated the burden...
10.
Sonderup M, Afihene M, Ally R, Apica B, Awuku Y, Cunha L, et al.
Lancet Gastroenterol Hepatol
. 2017 Nov;
2(12):910-919.
PMID: 29132760
In 2016, WHO adopted a strategy for the elimination of viral hepatitis by 2030. Africa, and more specifically, sub-Saharan Africa, carries a substantial portion of the global burden of viral...